We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Xerox Attempts Hostile Takeover With New Tender Offer for HP
Read MoreHide Full Article
Xerox Holdings Corporation (XRX - Free Report) yesterday launched a hostile takeover attempt with a $24-a-share tender offer to acquire all outstanding shares of HP (HPQ - Free Report) . The offer comprises $18.4 in cash and 0.149 Xerox shares for each HP share.
“Our proposal offers progress over entrenchment,” said Xerox chief executive officer John Visentin. “HP shareholders will receive $27 billion in immediate, upfront cash while retaining significant, long-term upside through equity ownership in a combined company with greater free cash flow to invest in growth and return to shareholders,” he added.
Xerox stated that it has secured financing from Citigroup (C - Free Report) , Bank of America (BAC - Free Report) , Mizuho Financial Group, Mitsubishi UFJ Financial Group, Credit Agricole, SunTrust Robinson Humphrey, Truist Financial and PNC Bank for the cash portion.
HP said that it will review the offer over 10 business days before deciding a course of action for shareholders.
The Tug of War
Xerox has been considering the buyout since May 2019 and revealed its takeover offer in November with a $22 per share bid. HP had rejected the offer, stating that the deal was undervalued and Xerox didn’t adequately explain its financial situation.
Xerox, in early February, increased the deal price to $24 a share and stated that it would launch a tender offer in March. HP went for “poison pill” defense, giving its shareholders the right to buy more shares at a discount if any individual or group acquires 20% of its outstanding shares. Thus, no one could accumulate more than 20% stake in the company.
To further complicate the situation, a HP sec filing last Thursday revealed that Activist investor Carl Icahn had intentions to buy the company if it didn’t pursue merger with Xerox.
What if They Merge?
Both the companies have been grappling with decreased demand for paper-related systems in an increasingly digital environment. Both lack certain capabilities that could be useful in a shrinking market.
Labels, packaging and signage for instance are fast growing areas of the market where HP shines but Xerox doesn’t have any offering. Similarly, the corporate copier business is where Xerox shines while HP has no presence.
So, if the merger materializes, it will enable Xerox to create a strong portfolio capable of catering to a wide range of printing needs.
Xerox earlier said that it expects the proposed combination to produce $2 billion in cost savings and more than $1 billion in additional revenue growth.
Shares of Xerox and HP have increased a respective 14.3% and 19.1% over the past six months, outperforming the 5.5% rally of the Zacks S&P 500 composite.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Xerox Attempts Hostile Takeover With New Tender Offer for HP
Xerox Holdings Corporation (XRX - Free Report) yesterday launched a hostile takeover attempt with a $24-a-share tender offer to acquire all outstanding shares of HP (HPQ - Free Report) . The offer comprises $18.4 in cash and 0.149 Xerox shares for each HP share.
“Our proposal offers progress over entrenchment,” said Xerox chief executive officer John Visentin. “HP shareholders will receive $27 billion in immediate, upfront cash while retaining significant, long-term upside through equity ownership in a combined company with greater free cash flow to invest in growth and return to shareholders,” he added.
Xerox stated that it has secured financing from Citigroup (C - Free Report) , Bank of America (BAC - Free Report) , Mizuho Financial Group, Mitsubishi UFJ Financial Group, Credit Agricole, SunTrust Robinson Humphrey, Truist Financial and PNC Bank for the cash portion.
HP said that it will review the offer over 10 business days before deciding a course of action for shareholders.
The Tug of War
Xerox has been considering the buyout since May 2019 and revealed its takeover offer in November with a $22 per share bid. HP had rejected the offer, stating that the deal was undervalued and Xerox didn’t adequately explain its financial situation.
Xerox, in early February, increased the deal price to $24 a share and stated that it would launch a tender offer in March. HP went for “poison pill” defense, giving its shareholders the right to buy more shares at a discount if any individual or group acquires 20% of its outstanding shares. Thus, no one could accumulate more than 20% stake in the company.
To further complicate the situation, a HP sec filing last Thursday revealed that Activist investor Carl Icahn had intentions to buy the company if it didn’t pursue merger with Xerox.
What if They Merge?
Both the companies have been grappling with decreased demand for paper-related systems in an increasingly digital environment. Both lack certain capabilities that could be useful in a shrinking market.
Labels, packaging and signage for instance are fast growing areas of the market where HP shines but Xerox doesn’t have any offering. Similarly, the corporate copier business is where Xerox shines while HP has no presence.
So, if the merger materializes, it will enable Xerox to create a strong portfolio capable of catering to a wide range of printing needs.
Xerox earlier said that it expects the proposed combination to produce $2 billion in cost savings and more than $1 billion in additional revenue growth.
Both Xerox and HP sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Shares of Xerox and HP have increased a respective 14.3% and 19.1% over the past six months, outperforming the 5.5% rally of the Zacks S&P 500 composite.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>